Median (min., max.) publication year | 2006 (1984, 2013) |
---|---|
Patients | Â |
Number of patients | Â |
- Sum | 7,024 |
- Median (min., max.) | 143 (29, 707) |
Recruitment | Â |
- Clinical | 19 |
- Screening | 16 |
- Mixed | 2 |
Restricted to patients > 55 years | 5 |
Diagnosis | Â |
- Major depression only | 14 |
- Depression (mixed/not exactly specified) | 16 |
- Mild/minor/subthreshold depression and/or dysthymia | 7 |
Overall risk of bias | Â |
- High (high risk in one or more items) | 13 |
- Unclear (no item high risk, < 3 low risk) | 11 |
- Low (at least 3 low, none high risk) | 13 |
Interventions | Â |
Psychological interventions | Â |
- Face-to-face cognitive behavioural psychotherapy (CBT; ≥ 6 sessions) | 9 |
- Face-to-face other problem-solving treatment (PST; ≥ 6 sessions) | 5 |
- Face-to-face interpersonal psychotherapy (≥ 6 sessions) | 3 |
- Face-to-face psychodynamic therapy (≥ 6 sessions) | 1 |
- Other face-to-face psychosocial interventions (≥ 6 sessions) | 8 |
- Remote therapist-led CBT (≥ 6 sessions) | 4 |
- Remote therapist-led PST (≥ 6 sessions) | 2 |
- Guided self-help CBT (up to 4 contacts) | 4 |
- No/minimal contact CBT (less than 30Â minutes contact) | 4 |
Pharmacotherapy | Â |
- Selective serotonin reuptake inhibitors (SSRI) | 6 |
- Tricyclic antidepressants | 3 |
- Individualized antidepressant | 1 |
Combinations psychological interventions and pharmacotherapy | Â |
- Face-to-face CBT + SSRI | 1 |
- Face-to-face PST + SSRI | 1 |
- Face-to-face interpersonal therapy + SSRI | 1 |
Contol interventions | Â |
- Placebo | 3 |
- Usual care | 27 |
Median length of treatment in weeks (min., max.) | 12 (6, 26) |
Median number of treatment sessions (min., max.) | 8 (0, 20) |
Data available for meta-analysis | Â |
Outcome response | 34 |
Outcome remission | 34 |
Outcome depression score data | 36 |
Outcome total number of patients discontinuing the study | 34 |